# SRI Krishna Pharmaceuticals Ltd - Unit I – FDA Inspection, Sep 1, 2023

Source: https://www.keypedia.com/records/fda_inspections/sri-krishna-pharmaceuticals-ltd-unit-i/abc43a24-1b12-4cba-9d71-bca900b6cd7d
Source feed: FDA_Inspections

> FDA inspection 1219348 of SRI Krishna Pharmaceuticals Ltd - Unit I, September 01, 2023. Classification: Official Action Indicated (OAI). Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1219348
- Company Name: SRI Krishna Pharmaceuticals Ltd - Unit I
- Inspection Date: 2023-09-01
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1271116 - 2025-04-18](https://www.keypedia.com/records/fda_inspections/sri-krishna-pharmaceuticals-ltd-unit-i/0e1bf9b9-cc93-4e79-a050-0f75cf3e14a8)
- FDA Inspection 928508 - 2015-05-15
- FDA Inspection 757323 - 2011-11-17

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/pratik-s-upadhyay/22ff2e0b-17d4-4c91-a3f0-c7e30b7a115b)
- [FDA Associated Person](https://www.keypedia.com/people/tamil-arasu/94efc491-7d9f-4221-a1ee-69a925acb1c3)

Company: https://www.keypedia.com/companies/sri-krishna-pharmaceuticals-ltd-unit-i/a8609781-dc13-4ad6-9bb3-047ead2bf151

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
